CS logo
small CS logo
Oncoclínicas Rio de Janeiro S.A.

Rio De Janeiro, Brazil

About Oncoclínicas Rio de Janeiro S.A.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Oncoclínicas Rio de Janeiro S.A.


During the past decade, Oncoclínicas Rio de Janeiro S.A. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Oncoclínicas Rio de Janeiro S.A." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Oncoclínicas Rio de Janeiro S.A.


According to Clinical.Site data, the most researched conditions in "Oncoclínicas Rio de Janeiro S.A." are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Advanced Solid Tumor" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Lymphoma, Mantle-Cell" (1 trials). Many other conditions were trialed in "Oncoclínicas Rio de Janeiro S.A." in a lesser frequency.

Clinical Trials Intervention Types at Oncoclínicas Rio de Janeiro S.A.


Most popular intervention types in "Oncoclínicas Rio de Janeiro S.A." are "Drug" (18 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (4 trials), "Carboplatin" (4 trials), "Erdafitinib" (4 trials), "Lazertinib" (3 trials) and "Pemetrexed" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Oncoclínicas Rio de Janeiro S.A.


The vast majority of trials in "Oncoclínicas Rio de Janeiro S.A." are 16 trials for "All" genders and 3 trials for "Male" genders.

Clinical Trials Status at Oncoclínicas Rio de Janeiro S.A.


Currently, there are NaN active trials in "Oncoclínicas Rio de Janeiro S.A.". undefined are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oncoclínicas Rio de Janeiro S.A., undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oncoclínicas Rio de Janeiro S.A., 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".